Arrowhead Pharmaceuticals ARWR
NASDAQ ARWR
$64.44 -0.35 (-0.53%)
As of: Oct 2, 2026 · 3:46 PM EDT

Arrowhead Pharmaceuticals (ARWR) Long-Term Investments (2010 - 2023)

Updated

Arrowhead Pharmaceuticals (ARWR) recorded Long-Term Investments of $42.8 million in fiscal Q3 2023 (quarter ended Jun 30, 2023), down 74.2% from $165.92 million a year earlier and down 45.7% from the prior quarter.

Analysis

Arrowhead Pharmaceuticals (ARWR) Long-Term Investments (2010 - 2023) Analysis & Trends

At the end of FY2022 (ended Sep 30, 2022), Arrowhead Pharmaceuticals reported Long-Term Investments of $105.87 million, down 56.9% from FY2021.

  • Annual Long-Term Investments has a three-year compound annual growth rate of 33.8% (FY2019 to FY2022).
  • Across earlier fiscal years, Long-Term Investments came in at $245.6 million in FY2021 (+78.6%), $137.49 million in FY2020 (+211.2%) and $44.18 million in FY2019.
  • The fiscal Q3 2023 figure is the lowest quarterly Long-Term Investments since fiscal Q1 2020.
  • On a year-over-year basis, Long-Term Investments has declined for four consecutive quarters, with growth averaging 9.0% over the last eight quarters.
  • Peak year-over-year performance for Long-Term Investments in the last five years was growth of 321.2% in fiscal Q1 2021, against a decline of 74.2% in fiscal Q3 2023 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $78.83 million (Q2 2023), $115.8 million (Q1 2023) and $105.87 million (Q4 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 266.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.22 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 69.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 2.62 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.56 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.79 Bn
10 Arrowhead Pharmaceuticals 9.24 Bn 4.02 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 42.80 Mn
Mar 31, 2023 78.83 Mn
Dec 31, 2022 115.80 Mn
Sep 30, 2022 105.87 Mn
Jun 30, 2022 165.92 Mn
Mar 31, 2022 201.60 Mn
Dec 31, 2021 217.60 Mn
Sep 30, 2021 245.60 Mn
Jun 30, 2021 128.40 Mn
Mar 31, 2021 97.50 Mn
Dec 31, 2020 110.90 Mn
Sep 30, 2020 137.49 Mn
Jun 30, 2020 177.53 Mn
Mar 31, 2020 190.62 Mn
Dec 31, 2019 26.33 Mn
Sep 30, 2019 44.18 Mn
Jun 30, 2019 57.56 Mn
Mar 31, 2019 67.54 Mn
Dec 31, 2018 59.60 Mn
Jun 30, 2018 17.67 Mn
API Access

Arrowhead Pharmaceuticals Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=ARWR&period=max&api_key=YOUR_API_KEY